Physician profile
Deanna Sinclair
NPI 1659938017
$974.26
in general payments reported to CMS, 2019-2025
13 companies · $24.46 in 2025
The $24.46 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $648 · 2022: $21.06 · 2023: $20.58 · 2024: $260 · 2025: $24.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $226.25 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $166.41 | 2021-2024 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $158.16 | 2021-2025 | Relistor |
| Biodelivery Sciences International, INC. | $83.14 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $68.15 | 2021 | |
| Almatica Pharma LLC | $61.19 | 2021 | |
| Lilly USA, LLC | $52.96 | 2021 | |
| Uswm, LLC | $37.50 | 2021 | |
| Abbvie INC. | $32.14 | 2024 | |
| Novartis Pharmaceuticals Corporation | $24.30 | 2021 | |
| Pfizer INC. | $23.16 | 2024 | |
| Seqirus USA INC | $20.58 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Alkermes, INC. | $20.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Sinclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.